Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis

Author： Tsang W.K. Tong K.L. Chan H.W.H.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.30, Iss.7, 1998-11, pp. : 3072-3073

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefit of Angiotensin II Receptor Blockade in the Treatment of Posttransplant Polycythemia in Renal Transplant Recipients

By Kupin W. Venkat K.K. Goggins M. Abouljoud M. Escobar F. Mozes M.

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 207-208

Elsevier

Access to resources Recommend Favorite

Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study

By Richter M.H.C. Richter H. Barten M. Schramm D. Gummert J. Mohr F.W. Skupin M. Olbrich H.G.

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1484-1485

Elsevier

Access to resources Recommend Favorite

Studies of erythroid burst-forming units in patients with posttransplant erythrocytosis

By Glicklich D. Kapoian T. Mian H. Greenstein S. Tellis V. Croizat H.

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1284-1285

Elsevier

Access to resources Recommend Favorite

Management of posttransplant erythrocytosis with enalapril

By Javid R. Ghahramani N. Malek-Hosseini S.A. Behzadi S. Rais-Jalali G.A.

Transplantation Proceedings, Vol. 31, Iss. 8, 1999-12 ,pp. : 3226-3226

Elsevier

Access to resources Recommend Favorite

Treatment of Posttransplant Erythrocytosis With Losartan

By Ducloux D. Fournier V. Bresson-Vautrin C. Chalopin J.M.

Transplantation Proceedings, Vol. 29, Iss. 5, 1997-08 ,pp. : 2407-2408

Elsevier

Access to resources Recommend Favorite